ISO-690 (author-date, English)

BARBOUR, Andrew B., KIRSTE, Simon, GROSU, Anca-Ligia, SIVA, Shankar, LOUIE, Alexander V., ONISHI, Hiroshi, SWAMINATH, Anand, TEH, Bin S., PSUTKA, Sarah P., WEG, Emily S., CHEN, Jonathan, ZENG, Jing, GORE, John L., HALL, Evan, LIAO, Jay J., CORREA, Rohann J. M. and LO, Simon S., 2023. The judicious use of stereotactic ablative radiotherapy in the primary management of localized renal cell carcinoma. Freiburg: Universität.

Elsevier - Harvard (with titles)

Barbour, A.B., Kirste, S., Grosu, A.-L., Siva, S., Louie, A.V., Onishi, H., Swaminath, A., Teh, B.S., Psutka, S.P., Weg, E.S., Chen, J., Zeng, J., Gore, J.L., Hall, E., Liao, J.J., Correa, R.J.M., Lo, S.S., 2023. The judicious use of stereotactic ablative radiotherapy in the primary management of localized renal cell carcinoma. Universität, Freiburg. https://doi.org/10.3390/cancers15143672

American Psychological Association 7th edition

Barbour, A. B., Kirste, S., Grosu, A.-L., Siva, S., Louie, A. V., Onishi, H., Swaminath, A., Teh, B. S., Psutka, S. P., Weg, E. S., Chen, J., Zeng, J., Gore, J. L., Hall, E., Liao, J. J., Correa, R. J. M., & Lo, S. S. (ca. 2023). The judicious use of stereotactic ablative radiotherapy in the primary management of localized renal cell carcinoma [Cd]. Universität. https://doi.org/10.3390/cancers15143672

Springer - Basic (author-date)

Barbour AB, Kirste S, Grosu A-L, Siva S, Louie AV, Onishi H, Swaminath A, Teh BS, Psutka SP, Weg ES, Chen J, Zeng J, Gore JL, Hall E, Liao JJ, Correa RJM, Lo SS (2023) The judicious use of stereotactic ablative radiotherapy in the primary management of localized renal cell carcinoma. Universität, Freiburg

Juristische Zitierweise (Stüber) (Deutsch)

Barbour, Andrew B./ Kirste, Simon/ Grosu, Anca-Ligia/ Siva, Shankar/ Louie, Alexander V./ Onishi, Hiroshi/ Swaminath, Anand/ Teh, Bin S./ Psutka, Sarah P./ Weg, Emily S./ Chen, Jonathan/ Zeng, Jing/ Gore, John L./ Hall, Evan/ Liao, Jay J./ Correa, Rohann J. M./ Lo, Simon S., The judicious use of stereotactic ablative radiotherapy in the primary management of localized renal cell carcinoma, Freiburg 2023.

Warning: These citations may not always be 100% accurate.